Citigroup’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-439
| Closed | -$23K | – | 7766 |
|
|
2020
Q3 | $23K | Sell |
439
-1,504
| -77% | -$92.8K | ﹤0.01% | 6114 |
|
|
2020
Q2 | $119K | Buy |
1,943
+105
| +6% | +$6.07K | ﹤0.01% | 5437 |
|
|
2020
Q1 | $104K | Buy |
1,838
+513
| +39% | +$29.2K | ﹤0.01% | 5314 |
|
|
2019
Q4 | $75K | Buy |
1,325
+522
| +65% | +$27.7K | ﹤0.01% | 6001 |
|
|
2019
Q3 | $43K | Sell |
803
-905
| -53% | -$52.7K | ﹤0.01% | 6224 |
|
|
2019
Q2 | $102K | Buy |
1,708
+244
| +17% | +$15.4K | ﹤0.01% | 5860 |
|
|
2019
Q1 | $92K | Buy |
1,464
+75
| +5% | +$4.96K | ﹤0.01% | 5830 |
|
|
2018
Q4 | $84K | Sell |
1,389
-107
| -7% | -$6.39K | ﹤0.01% | 5808 |
|
|
2018
Q3 | $87K | Buy |
1,496
+483
| +48% | +$24.6K | ﹤0.01% | 6038 |
|
|
2018
Q2 | $45K | Sell |
1,013
-1,119
| -52% | -$48.1K | ﹤0.01% | 6371 |
|
|
2018
Q1 | $94K | Sell |
2,132
-80
| -4% | -$3.36K | ﹤0.01% | 5677 |
|
|
2017
Q4 | $96K | Sell |
2,212
-1,061
| -32% | -$47.7K | ﹤0.01% | 5681 |
|
|
2017
Q3 | $152K | Buy |
3,273
+2,206
| +207% | +$106K | ﹤0.01% | 5218 |
|
|
2017
Q2 | $53K | Buy |
1,067
+119
| +13% | +$6.23K | ﹤0.01% | 5750 |
|
|
2017
Q1 | $52K | Sell |
948
-4,493
| -83% | -$238K | ﹤0.01% | 5674 |
|
|
2016
Q4 | $303K | Buy |
5,441
+1,977
| +57% | +$95K | ﹤0.01% | 4922 |
|
|
2016
Q3 | $158K | Buy |
3,464
+2,053
| +145% | +$82.5K | ﹤0.01% | 4855 |
|
|
2016
Q2 | $56K | Sell |
1,411
-2,715
| -66% | -$99.4K | ﹤0.01% | 5504 |
|
|
2016
Q1 | $143K | Buy |
4,126
+2,025
| +96% | +$74.3K | ﹤0.01% | 5400 |
|
|
2015
Q4 | $90K | Buy |
+2,101
| New | +$105K | ﹤0.01% | 5458 |
|
|
2015
Q3 | – | Sell |
-1,839
| Closed | -$95K | – | 7907 |
|
|
2015
Q2 | $95K | Buy |
1,839
+1,630
| +780% | +$69.5K | ﹤0.01% | 5048 |
|
|
2015
Q1 | $8K | Sell |
209
-11,217
| -98% | -$440K | ﹤0.01% | 6570 |
|
|
2014
Q4 | $441K | Buy |
11,426
+11,298
| +8,827% | +$431K | ﹤0.01% | 4000 |
|
|
2014
Q3 | $5K | Buy |
128
+72
| +129% | +$2.11K | ﹤0.01% | 6590 |
|
|
2014
Q2 | $2K | Buy |
+56
| New | +$1.46K | ﹤0.01% | 6810 |
|
|
2013
Q4 | – | Sell |
-98
| Closed | -$2K | – | 7220 |
|
|
2013
Q3 | $2K | Buy |
+98
| New | +$1.74K | ﹤0.01% | 6613 |
|
Other funds holding BSTC
Citigroup's BSTC Position: Q4 2020 in Review
Citigroup sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 439 shares — an estimated $23K sold.
Citigroup first reported a position in BSTC in Q3 2013 and held it in 26 quarters. The position peaked at $441K in Q4 2014. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- Citigroup reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- Citigroup sold 439 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $23K.
- Citigroup first reported a position in BioSpecifics Technologies Corp. in Q3 2013 and held it in 26 quarters.
- Citigroup's BioSpecifics Technologies Corp. position peaked at $441K in Q4 2014.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on Citigroup's 13F filing for Q4 2020, filed 11 Feb 2021.